Cell Culture Models for Hepatitis B and D Viruses Infection: Old Challenges, New Developments and Future Strategies

被引:1
|
作者
Carpentier, Arnaud [1 ,2 ,3 ]
机构
[1] Joint Venture Hannover Med Sch MHH & Helmholtz Ctr, TWINCORE Ctr Expt & Clin Infect Res, Inst Expt Virol, Feodor Lynen Str 7, D-30625 Hannover, Germany
[2] Hannover Med Sch, Cluster Excellence RESIST EXC 2155, Hannover, Germany
[3] Hannover Med Sch, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源
VIRUSES-BASEL | 2024年 / 16卷 / 05期
关键词
Hepatitis B Virus; Hepatitis D Virus; primary hepatocytes; hepatoma cell lines; HLCs; cell culture; model; ADULT HUMAN HEPATOCYTES; INNATE RESPONSE; HUMAN-LIVER; STEM-CELLS; IN-VITRO; HBV; REPLICATION; EXPRESSION; IMMUNITY; GENOME;
D O I
10.3390/v16050716
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Chronic Hepatitis B and D Virus (HBV and HDV) co-infection is responsible for the most severe form of viral Hepatitis, the Hepatitis Delta. Despite an efficient vaccine against HBV, the HBV/HDV infection remains a global health burden. Notably, no efficient curative treatment exists against any of these viruses. While physiologically distinct, HBV and HDV life cycles are closely linked. HDV is a deficient virus that relies on HBV to fulfil is viral cycle. As a result, the cellular response to HDV also influences HBV replication. In vitro studying of HBV and HDV infection and co-infection rely on various cell culture models that differ greatly in terms of biological relevance and amenability to classical virology experiments. Here, we review the various cell culture models available to scientists to decipher HBV and HDV virology and host-pathogen interactions. We discuss their relevance and how they may help address the remaining questions, with one objective in mind: the development of new therapeutic approaches allowing viral clearance in patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection
    Verrier, Eloi R.
    Colpitts, Che C.
    Schuster, Catherine
    Zeisel, Mirjam B.
    Baumert, Thomas F.
    VIRUSES-BASEL, 2016, 8 (09):
  • [2] In vitro cell culture models to study hepatitis B and D virus infection
    Guo, Hongbo
    Urban, Stephan
    Wang, Wenshi
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [3] Establishment of a Cell Culture Model Permissive for Infection by Hepatitis B and C Viruses
    Otoguro, Teruhime
    Tanaka, Tomohisa
    Kasai, Hirotake
    Kobayashi, Nobuhiro
    Yamashita, Atsuya
    Fukuhara, Takasuke
    Ryo, Akihide
    Fukai, Moto
    Taketomi, Akinobu
    Matsuura, Yoshiharu
    Moriishi, Kohji
    HEPATOLOGY COMMUNICATIONS, 2021, 5 (04) : 634 - 649
  • [4] Cell Culture Models for the Study of Hepatitis D Virus Entry and Infection
    Heuschkel, Margaux J.
    Baumert, Thomas F.
    Verrier, Eloi R.
    VIRUSES-BASEL, 2021, 13 (08):
  • [5] Management of chronic hepatitis B infection: Current treatment guidelines, challenges, and new developments
    Tang, Ceen-Ming
    Yau, Tung On
    Yu, Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (20) : 6262 - 6278
  • [6] Management of chronic hepatitis B infection: Current treatment guidelines, challenges, and new developments
    Ceen-Ming Tang
    Tung On Yau
    Jun Yu
    World Journal of Gastroenterology, 2014, 20 (20) : 6262 - 6278
  • [7] Animal Models of Hepatitis B Virus Infection-Success, Challenges, and Future Directions
    Liu, Yongzhen
    Maya, Stephanie
    Ploss, Alexander
    VIRUSES-BASEL, 2021, 13 (05):
  • [8] Hepatitis B infection: current concepts and future challenges
    Nebbia, G.
    Peppa, D.
    Maini, M. K.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2012, 105 (02) : 109 - 113
  • [9] Developments in 3D neural cell culture models: the future of neurotherapeutics testing?
    Ko, Kristin Robin
    Frampton, John P.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (07) : 739 - 741
  • [10] HIV/hepatitis B virus co-infection: current challenges and new strategies
    Lacombe, K.
    Bottero, J.
    Lemoine, M.
    Boyd, A.
    Girard, P. M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (01) : 10 - 17